¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°í·Á´ëÇб³¾È¾Ïº´¿ø Myocardial Ischemia Symposium In Korea 2019 : 2019-03-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°í·Á´ëÇб³¾È¾Ïº´¿ø Myocardial Ischemia Symposium In Korea 2019 : 2019-03-08​
±³À°ÀÏÀÚ : 2019-03-08
±³À°Àå¼Ò : Millennium Seoul Hilton(Grand Ballroom A, B, Junior Ballroom A, B, C)  
±³À°ÁÖÁ¦ : Myocardial Ischemia Symposium In Korea 2019
ÁÖÃÖ±â°ü : °í·Á´ëÇб³¾È¾Ïº´¿ø
´ã´çÀÚ : ¹èÁø¼º
¿¬¶ôó : 02-920-6715  
À̸ÞÀÏ : mwvagabond@naver.com      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 550¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 16 ½Ã°£ 5ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom A) 08:00~08:20 A Fib and Stroke (or Stroke Prevention in A Fib)  ÀÓÈ«ÀÇ(°í´ë±¸·Îº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom A) 08:20~08:40 PFO Closure for Prevention of Stroke  Á¶À±Çü(¸íÁöº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom A) 08:40~09:00 Asymptomatic Carotid Stenosis, When to Treat?  ¹®ÁÖ¼±(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom B) 08:00~08:20 New Anti-diabetic Agents ; Saving Life?  Á¤Àΰæ(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom B) 08:20~08:40 LDL Cholesterol, The Lower is The Better  ±è³²ÈÆ(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom B) 08:40~09:00 Blood Thinning Medication is Essential to Reduce CV Death  Á¤¿µÈÆ(°æ»ó´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom C) 08:00~08:20 Dont Ignore Missing Values: Missing Value Imputation  ¾ÈÇüÁø(°í·Á´ëÇб³) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom C) 08:20~08:40 Things to Know about Meta-analysis  ÀÌÁØ¿µ(°í·Á´ëÇб³) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Junior Ballroom C) 08:40~09:00 New Statistical Approach: Causal Medication Analysis  À̵¿ÈÆ(°í·Á´ëÇб³) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 09:05~09:20 What Are The New Devices and Their Outcomes in Renal Denervation?  ±èº´±Ø(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 09:20~09:40 What Are Carotid Neuromodulation and Arterio-venous Fistula Creation in Hypertension Control  ¹ÚÀçÇü(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 09:40~10:00 Novel Medications in The Treatment of Hypertension  ¼ÕÀϼ®(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 10:00~10:20 What Are The Suggested Mechanisms of Resistant Hypertension and Its Management  ÀÓ»óÇö(ºÎõ¼º¸ðº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 10:35~11:00 Recent Update in IVUS-guided vs Angiography-guided PCI in ACS  Bill D. Gogas(Nanjing First Hospital, China) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 11:00~11:20 What is The Role of NIRS in ACS  Á¤ÇÑ»ù(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 11:20~11:45 Cardiac CT Focused on CTO or Calcification  Masaaki Okutsu(New Tokyo Hospital, Japan) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 11:45~12:00 How The Pre-procedural Coronary CT Imaging Changed My Practice  ÃÖÁøÈ£(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 12:00~12:20 Cardiogenic Shock - Complex Clinical Interplay  ¾Èö¹Î(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 12:20~12:40 Tips to Reduce ECMO Duration and ICU Stay  ÀÓÁÖ¿µ(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 12:40~13:00 Predicting and Treating Sudden Death  Samuel Calvert Dudley(University of Minnesota, USA) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:00~13:15 Which Patients Can Benefit from CTO Revascularization: Criteria for Selecting Patients for CTO PCI  ±¹Çüµ·(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:15~13:30 What Are The New Devices in CTO PCI and How Can We Use Them?  À±ÇõÁØ(°è¸í´ëµ¿»êÀÇ·á¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:30~13:45 Role of Intracoronary Imaging in CTO Intervention  À̽Âȯ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 13:45~14:00 Selecting Patient Criteria for Antegrade vs. Retrograde CTO PCI  ¹Ú»óÈ£(¼øõÇâ´ëõ¾Èº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:00~14:15 What is Important Anatomy in Echocardiography to Close a PFO and LAA?  È«±×·ç(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:15~14:35 How Can We Use a CT for PFO and LAA in Clinical Practice?  Á¶Àͼº(Á߾Ӵ뺴¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:35~14:55 Close a PFO: Who is an Appropriate Candidate and What is a Cirital Issue?  Teiji Akagi(Okayama University Hospital, Japan) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 14:55~15:15 Close a LAAO: Who is an Appropriate Candidate and What is a Critical Issue?  Simon Lam(University of Hong Kong, Hong Kong) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 15:30~15:50 Imaging Guidance during Aortic Valve Intervention: Do We Need it?  È«±×·ç(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 15:50~16:15 TAVI for Bicuspid Aortic Valve  Ariel Finklestein(Tel Aviv Medical Center, Israe) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 16:15~16:40 Durability of TAVI Valves  Jian Ye(University of British Columbia, Canada) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom A) 16:40~17:00 Clinical Evidences for Sutureless Aortic Valves  À̽ÂÇö(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 09:05~09:20 Mobile Application for Cardiac Rehabilitation  ±èÀÀÁÖ(°í´ë±¸·Îº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 09:20~09:40 Advancing 12-lead ECG-based Care System in Emergency Settings  Â÷¿øö(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 09:40~10:00 Surveillence of Adverse Drug Reaction by Using Electronic Health Records  À̼öÇö(°Ç¾ç´ëÇб³) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 10:00~10:20 AI Application in Cardiovascular Imaging  ¾çµ¿Çö(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 10:35~11:00 The Future of Myocardial Injury Biomarkers in Cardiovascular Disease  Michael Marbe(The Rayne Institute, UK) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 11:00~11:25 Protease-Cathepsins as Biomaker and/or Biomarker in Vascular Aging and Cardiovascular Disease  Xian Wu Cheng(Nagoya University Graduate School of Medicine, Japan) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 11:25~11:40 Discovery of Novel Biomarkers: Recent Proteomics  ÀÌÁöÀº(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 11:40~12:00 Microfluidic Platform technology for diagnostic immunoassay  Á¤¼®(°í·Á´ëÇб³) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 12:00~12:20 Controversies in Statin and Vascular Calcification - Can We Neglect?  ±è»ó¹Î(ÃæºÏ´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 12:20~12:40 How about Initial Ezetimibe Combination?  ¿øÈ£¿¬(Á߾Ӵ뺴¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 12:40~13:00 Potential Implications of PCSK9 Inhibitors for Korean Patients?  ÀÌ»óÇÐ(¿¬¼¼´ëÇб³) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 13:00~13:20 Incidence of Stent Failure, Periodical Changes from BMS to 2nd Generation DES  ±è¼öÁß(°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 13:20~13:40 IVUS is Essential to Evaluate The Cause of Stent Failure  ±è»ó¹Î(ÃâºÏ´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 13:40~14:00 How to Use FFR in The Patients with Instent Restenosis  µµÁØÇü(ÀÎÁ¦´ëÀÏ»ê¹éº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 14:00~14:20 How to Treat: Left Main ISR with/without Bifurcation  ¾ÈÁ¤¹Î(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 14:20~14:40 What You Need to Know for ISR CTO Intervention  ÀÌÀåÈÆ(°æºÏ´ëº´¿ø) 
±³À°½Ã°£ 03-08 Millennium Seoul Hilton (Grand Ballroom B) 14:40~15:00 How to Deal The Patient with Long ISR Lesion  ½ÅÀº¼®(¿ï»êº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °í·Á´ëÇб³¾È¾Ïº´¿ø Myocardial Ischemia Symposium In Korea 2019 : 2019-03-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø ´ëÇѳúÀüÁõÇÐȸ Cannabinoids for epilepsy : 2019-03-08
´ÙÀ½±Û ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2019 Innovation in Thoracic Surgery Symposium : 2019-03-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 49 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 27 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 24 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 21 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷